Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Liposarcoma, Myxoid × baricitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Liposarcoma, Myxoid 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Chondrosarcoma 1

Interventions

Cyclophosphamide 9 fludarabine 5 seclidemstat 1 pembrolizumab 1 itacitinib 1 fludarabine phosphate 1 baricitinib 1 aldesleukin 1 Topotecan 1 Radiation 1 INCB039110 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03670069 2024-05-08

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Fred Hutchinson Cancer Center

Phase 1 Terminated

Chondrosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡